RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Endogenous ß-adrenergic input has been hypothesized to control patterns of cellular maturation in sympathetic target tissues by providing a timing signal for patterns of cell replication, differentiation, and responsiveness. In the current study, we examined the consequences of fetal exposure to a ß-agonist, terbutaline (2 or 10 mg/kg on gestational d 17, 18, and 19), in developing rat lung and liver, as assessed with ornithine decarboxylase activity and measurements of tissue macromolecules. Drug treatment caused an acute stimulation of ornithine decarboxylase in fetal and neonatal lung and blunted the peak of enzyme activity seen at 20-30 d postnatally without affecting acute responsiveness to ß-adrenergic stimulation (isoproterenol). Consistent with these results, patterns of cell replication and differentiation were altered, characterized by a deficit in cell acquisition (DNA content); in the tissue displaying fetal ODC stimulation (lung), there was also evidence for developmental abnormalities in RNA and protein. Thus, by prematurely stimulating ß-adrenergic receptors, prenatal administration of adrenergic agonists may have long-lasting, adverse effects on tissue development and responsiveness.